Emerging Markets Earnings Roundup: Amgen, Novartis (Part 3)
This article was originally published in PharmAsia News
Executive Summary
Amgen talked up its international expansion efforts while Novartis painted a picture of the growing importance of emerging markets to its bottom line. And both companies see biosimilars as a key play in emerging markets.